Comet Therapeutics
Cambridge, US · Founded 2018 · Delaware corporation · 2 known investors
Founders & leadership
EK
ENEJ KUSCER, PH.D.Named on SEC filing
PV
PETER VAN VLASSELAER, PH.D.Named on SEC filing
HR
HENRIJETTE RICHTER, PH.D.Named on SEC filing
BM
BERNARDUS MACHIELSENamed on SEC filing
LD
LUCAS DE BREEDNamed on SEC filing
DD
DAVID DE GRAAF, PH.D.Named on SEC filing
AT
ART TAVERAS, PH.D.Named on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.1M disclosed across 1 round · 2019
▶$14.1MraisedJun 2019 · 4 investors · Other TechnologyRule 506(b)
▶$14.1MraisedJun 2019 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- ENEJ KUSCER, PH.D.Executive Officer
- PETER VAN VLASSELAER, PH.D.Director
- HENRIJETTE RICHTER, PH.D.Director
- BERNARDUS MACHIELSEDirector
- LUCAS DE BREEDDirector
- DAVID DE GRAAF, PH.D.Executive Officer, Director
- ART TAVERAS, PH.D.Executive Officer
- Offering amount
- $14.1M
- Amount sold
- $14.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Comet Therapeutics's investors?
- Comet Therapeutics's investors include Mission Biocapital, Sofinnova Partners.
- How much funding has Comet Therapeutics raised?
- Comet Therapeutics has disclosed $14.1M raised across 1 round.
- Where is Comet Therapeutics headquartered?
- Comet Therapeutics is headquartered in Cambridge, US.